LGP6 Patents Grant
Apellis Pharmaceuticals gets grant for treatment of complement-mediated eye disorder with long-acting compstatin analog
Apellis Pharmaceuticals has been granted a patent for cell-reactive compstatin analogs to treat complement-mediated disorders. The method involves administering long-acting…
Ipsen gets grant for treatment of diseases with specific benzothiazepine and benzothiadiazepine derivatives
Ipsen has been granted a patent for certain 1,5-benzothiazepine and 1,2,5-benzothiadiazepine derivatives as bile acid modulators with potential in treating…
Seres Therapeutics gets grant for composition of isolated bacteria in capsule for dysbiosis treatment
Seres Therapeutics has been granted a patent for a composition containing specific bacterial species encapsulated in a capsule, aimed at…
BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment
BioCryst Pharmaceuticals has been granted a patent for compounds that inhibit the complement system, potentially treating diseases with abnormal complement…
MacroGenics gets grant for patent granted for compounds targeting IL23a and BAFF
MacroGenics has been granted a patent for compounds targeting IL23A and BAFF, with methods for suppressing inflammatory responses. The patent…